MARYAM ALIMIRAH

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology WESTLAKE, OH NPI 1801328281

General Payments — all program years on this page

$558.54

  • Category: General Payments
  • Program years: PY2024
  • Record count: 19
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $558.54 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $525.2016
Education $33.343

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $192.166
Lilly USA, LLC $155.703
PFIZER INC. $121.846
GENZYME CORPORATION $45.442
Merck Sharp & Dohme Corporation $23.381
Ardelyx, Inc. $20.021

By program year

Program yearAmountRecords
2024 $558.5419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1131161851 PFIZER INC. $18.28 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131605619 PFIZER INC. $17.47 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131628137 PFIZER INC. $22.69 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131661440 PFIZER INC. $19.46 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131691810 PFIZER INC. $22.31 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131941185 PFIZER INC. $21.63 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135170032 Lilly USA, LLC $21.11 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135170034 Lilly USA, LLC $29.32 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135170036 Lilly USA, LLC $105.27 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137467654 Takeda Pharmaceuticals U.S.A., Inc. $12.81 04/18/2024 Education Undisputed 01/23/2026 View at CMS
1137467658 Takeda Pharmaceuticals U.S.A., Inc. $11.51 05/13/2024 Education Undisputed 01/23/2026 View at CMS
1137467662 Takeda Pharmaceuticals U.S.A., Inc. $9.02 06/24/2024 Education Undisputed 01/23/2026 View at CMS
1137467666 Takeda Pharmaceuticals U.S.A., Inc. $125.00 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137467669 Takeda Pharmaceuticals U.S.A., Inc. $12.49 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137467673 Takeda Pharmaceuticals U.S.A., Inc. $21.33 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139901828 GENZYME CORPORATION $26.67 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139901876 GENZYME CORPORATION $18.77 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141818229 Merck Sharp & Dohme LLC $23.38 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146668421 Ardelyx, Inc. $20.02 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.